TTVR Early Feasibility Study
AI Description
The objective of this early feasibility study is to gain early clinical insight into the performance of the Intrepid transcatheter tricuspid valve replacement (TTVR) system intended for transfemoral access to deliver a self-expanding bioprosthetic valve within the tricuspid valve.
- Who can join
- adult, older adult
- Participants
- 150
- Expected completion
- 2031-08-26
- Funded by
- industry
Conditions studied
Tricuspid Regurgitation
What is being tested
- DEVICE: Intrepid™ TTVR System
What it measures
- Rate of implant or delivery related serious adverse events, Rate of implant or delivery related serious adverse events, Through 30 days post-procedure
Centers Participating
These centers are participating in this study. Reach out to them directly to learn more.
Abbott Northwestern Hospital
Minneapolis, MN
Aurora St. Luke's Medical Center
Milwaukee, WI
Cedars-Sinai Medical Center
Los Angeles, CA
Corewell Health Butterworth Hospital
Grand Rapids, MI
Emory University Hospital Midtown
Atlanta, GA
Hartford Hospital
Hartford, CT
Houston Methodist Hospital
Houston, TX
Montefiore Einstein Hospital (Moses Campus)
Bronx, NY
OhioHealth Riverside Methodist Hospital
Columbus, OH
OHSU Hospital
Portland, OR
Providence St. Patrick Hospital
Missoula, MT
The Christ Hospital
Cincinnati, OH
The Mount Sinai Hospital
New York, NY
UAB Hospital
Birmingham, AL
University Hospitals Cleveland Medical Center
Cleveland, OH
University of Michigan Health System
Ann Arbor, MI
UPMC Harrisburg
Harrisburg, PA
Registry entry updated 2026-09-15
Deciding whether to join a study is your choice, and you can ask a study team questions before you decide anything.
If you would rather we did it with you, call us on (656) 206-4686.